OpenAI has released LifeSciBench, a comprehensive benchmark that exposes a fundamental weakness in today's AI agents: they struggle significantly when asked to perform real-world scientific research tasks. The benchmark contains 750 expert-authored tasks spanning genomics, medicinal chemistry, and clinical science, with the strongest model achieving only a 36.1% pass rate. This finding has direct implications for how AI agents are being deployed in research environments and suggests that current agentic frameworks need substantial improvements before they can reliably assist scientists with complex, multi-step workflows.

Why Does This Matter for AI Agents and Agentic Frameworks?

The LifeSciBench results highlight a critical challenge for agentic AI systems: real-world scientific work is messier and more demanding than the benchmarks typically used to evaluate large language models (LLMs). Traditional benchmarks ask narrow, fact-based questions with clean answers. Scientists, by contrast, must weigh imperfect evidence, make judgment calls, and navigate complex decision trees. LifeSciBench was designed specifically to bridge this gap.

The benchmark evaluated five models in a single-turn setting, meaning each AI agent saw the prompt and supporting materials only once, with unrestricted internet browsing permitted. GPT-Rosalind, OpenAI's domain-specialized model trained specifically for life sciences, led the pack with a 36.1% pass rate, compared to GPT-5.5's 25.7%. Even this specialized agent failed nearly two out of every three tasks, suggesting that current agentic frameworks lack the reasoning depth and artifact-handling capabilities that real scientific work demands.

What Makes These Tasks So Difficult for AI Agents?

The benchmark's design reveals why AI agents are struggling. Around 79% of the 750 tasks require multiple reasoning or decision-making steps, averaging four steps each. This multi-step requirement is precisely where agentic systems often falter. While individual LLMs can answer isolated questions, orchestrating a series of dependent reasoning steps across different domains remains a significant bottleneck.

Artifact handling emerged as the single largest weakness. GPT-Rosalind's performance dropped sharply from 45.1% on text-only tasks to just 28.1% on tasks requiring analysis of supporting materials like sequences, figures, tables, PDFs, and chemical structures. This gap is particularly concerning because real scientific work almost always involves interpreting visual data, molecular structures, and complex documents. Current agentic frameworks struggle to integrate multimodal information effectively, a limitation that directly undermines their usefulness in research settings.

Two specific workflows proved especially challenging for all models tested. Design, optimization, and prediction tasks saw GPT-Rosalind achieve only a 30.7% pass rate, while analysis tasks came in at 30.3%. These are precisely the kinds of open-ended, creative tasks that scientists perform regularly, suggesting that agentic AI systems need fundamental improvements in their ability to synthesize information and generate novel solutions.

How to Evaluate AI Agents for Scientific Research Tasks

Organizations considering deploying AI agents in research environments should assess their capabilities across several key dimensions:

• Multi-step reasoning: Test whether the agent can maintain context and logical consistency across four or more sequential reasoning steps without losing track of earlier conclusions or constraints.
• Artifact interpretation: Evaluate how well the agent handles non-text inputs, including molecular structures, scientific figures, tables, and PDF documents, since this is where current systems show the largest performance gaps.
• Rubric-based grading: Use detailed, multi-criteria evaluation rubrics rather than simple pass-fail metrics, as partial credit often masks significant reasoning failures that could lead to incorrect scientific conclusions.
• Domain specialization: Consider whether a general-purpose agent or a domain-specialized model better suits your research needs, recognizing that even specialized models like GPT-Rosalind have substantial room for improvement.
• Iterative workflows: Remember that LifeSciBench evaluated single-turn interactions; real research is iterative and multi-turn, so test agents in realistic, back-and-forth scenarios rather than isolated prompts.

The benchmark itself was constructed with extraordinary rigor. A cohort of 173 expert scientists, each holding a Ph.D. and possessing biotechnology or pharmaceutical experience, authored the tasks. Each accepted task underwent an average of six automated review cycles and at least two expert reviews. A separate validation cohort of 453 reviewers, 97% of whom held doctorates, confirmed quality, with overall agreement exceeding 96% on relevance, reasoning, grounding, and usefulness.

The grading system itself is notably sophisticated. Rather than comparing responses to a single reference answer, LifeSciBench uses detailed rubrics containing 19,020 criteria across all tasks, averaging roughly 25 criteria per task. Each criterion rewards one concrete property, such as a specific fact, a reasoning step, or a numeric answer within a specified tolerance. This approach allows for partial credit while maintaining a strict 70% threshold for task-level success, preventing models from receiving credit for responses that are partially correct but ultimately unreliable for scientific purposes.

What Do the Results Tell Us About Current Agentic Limitations?

The data reveals a troubling pattern: models frequently stall mid-task. For GPT-Rosalind, 109 tasks earned at least 50% of available rubric points but still fell below the 20% pass rate threshold. This suggests that agents often begin reasoning correctly but fail to complete the task successfully, a failure mode that is particularly dangerous in scientific contexts where incomplete analysis can lead to incorrect conclusions.

Exact outputs proved hardest of all. Sequence and structure criteria, which require the agent to generate specific molecular sequences or structural predictions, showed success rates ranging from 46.9% to just 18.0% across different models. Even GPT-Rosalind's advantage over GPT-5.5 on generative tasks was minimal, with a gain of only 0.001 on construct-and-generate items. This suggests that current agentic frameworks lack the precision needed for tasks requiring exact, verifiable outputs.

The headroom for improvement remains substantial. No model passed 171 tasks, representing 22.8% of the benchmark. Additionally, 261 tasks, or 34.8% of the total, had a best-model pass rate below 20%, indicating entire categories of scientific reasoning where even the strongest current agents perform poorly. These gaps point to fundamental limitations in how agentic systems approach complex, multi-domain reasoning problems.

LifeSciBench represents a significant step forward in evaluating AI agents for real-world scientific work. By moving beyond narrow, fact-based questions to embrace the messy, iterative nature of actual research, the benchmark exposes critical weaknesses in current agentic frameworks. Organizations deploying AI agents in research settings should view these results as a cautionary tale: current systems can assist with specific subtasks but are not yet ready to operate autonomously on complex scientific problems without substantial human oversight and validation.